abstract |
The present disclosure generally relates to a composition comprising one or more peptides selected from influenza virus antigenic peptides M2 e , HA0, BM2 and a M2 e -BM2 fusion peptide in a composition with a cationic liposome delivery vehicle, and the use of these compositions as a universal vaccine against influenza A and/or B viral strains. |